Chiron Real Estate Inc. annual report, FY2018

Full document

Business Context and Reporting Period

Filing identity: The filing is Global Medical REIT Inc.’s Form 10-K for the fiscal year ended December 31, 2018, signed March 11, 2019. This differs from the request metadata naming Chiron Real Estate Inc. The filing reports annual results, not a standalone fourth-quarter report.

Global Medical REIT acquires purpose-built healthcare properties and leases them, generally on long-term triple-net terms, to healthcare systems and physician groups. At year-end it reported 50 facilities, approximately 2.08 million rentable square feet, and $50.2 million of annualized base rent. It is externally managed and elected REIT status beginning in 2016.

Financial and Operating Performance

  • Revenue: $53.2 million in 2018, up from $30.3 million in 2017; rental revenue was $49.6 million, versus $28.5 million. Growth primarily reflected acquisitions and a full year of rent from properties acquired in 2017.
  • Profit: Net income was $14.6 million, compared with a $0.1 million net loss in 2017. The 2018 result included a $7.7 million gain on the sale of Great Bend Regional Hospital. Net income attributable to common stockholders was $7.7 million, or $0.35 per share, versus a $1.8 million loss, or $(0.09) per share.
  • REIT measures: FFO was $19.0 million, or $0.78 per share; AFFO was $18.4 million, or $0.76 per share. Both are non-GAAP measures as defined by the company.
  • Cash flow: Operating cash flow was $24.8 million, up from $12.6 million. Investing activities used $151.6 million, including $180.8 million for property acquisitions, partly offset by $31.6 million of net sale proceeds. Financing activities provided $124.5 million. Cash and restricted cash declined to $4.8 million from $7.1 million.
  • Assets and liquidity: Net real estate investment was $616.9 million; total assets were reported as $636.1 million in the balance sheet. The filing’s selected-financial-data table instead reports total assets of $636.0 million, a discrepancy to verify. Year-end stockholders’ equity, including noncontrolling interest, was $299.8 million.
  • Debt: Debt net of unamortized discounts was $315.0 million, versus $200.7 million in 2017. The weighted-average year-end interest rate rose to 4.64% from 3.72%. Approximately 84% of properties were pledged under the credit facility. The company hedged the LIBOR component on $170 million of borrowings; it estimated a $1.1 million annual cash-flow reduction from a 100-basis-point LIBOR increase on its stated variable-rate exposure.
  • Margins: The filing does not provide a standard operating-margin measure. Income before the property-sale gain was $6.9 million; interest expense was $15.0 million.
  • Dividends: Common dividends remained $0.80 per share for the year. Series A preferred dividends were $1.875 per share annually, a 7.5% rate on liquidation preference. The filing says $0.70 of 2018 common dividends was treated as return of capital for tax purposes.

Material Changes Versus 2017

  • The company completed 14 acquisitions totaling approximately $196.3 million in purchase price and 811,707 square feet; gross real estate investment increased to $647.6 million from $471.5 million.
  • Great Bend Regional Hospital was sold in December for $32.5 million gross proceeds, producing the $7.7 million gain.
  • Net income improved substantially, although the reported profit included the sale gain. AFFO per share increased to $0.76 from $0.54; common dividends per share were unchanged.
  • Interest expense rose to $15.0 million from $7.4 million, reflecting higher average borrowings and higher rates. The company amended its credit facility, extending the revolver to August 2022 and adding a $100 million term loan.
  • Common-stock offerings generated $37.3 million of net proceeds, and the company issued $16.4 million of OP Units in connection with acquisitions. Outstanding common shares increased to 25.9 million from 21.6 million.

Outlook, Risks, Contingencies, and Unusual Items

  • Outlook: No quantified company earnings or acquisition guidance is provided. Management cited healthcare spending growth, an aging population, outpatient-care shifts, and a fragmented property market as potential opportunities, while identifying rising short-term rates, leverage limits, and healthcare reimbursement pressure as headwinds.
  • Acquisition pipeline: Through March 1, 2019, the filing lists East Valley Gastro in Arizona at $16.1 million as “Completed,” but also says the company was still conducting due diligence. AMG Specialty Hospital in Louisiana, at a contractual $4.5 million, was under contract. The East Valley status is inconsistent within the filing.
  • Concentration: The five largest tenants represented 39.3% of annualized base rent. Texas accounted for 22.9%, Ohio 13.8%, and Pennsylvania 12.2%. Tenant defaults, healthcare reimbursement changes, and local economic conditions could affect rent collection.
  • Leverage and distributions: The credit facility imposes leverage, fixed-charge-coverage, and other covenants. Common-stockholder distributions are limited to 95% of AFFO beginning at the end of the fourth quarter of 2019 under the disclosed facility terms. The company’s 2018 common dividend exceeded reported AFFO per share.
  • Other risks: The company relies on its external manager, has floating-rate debt and LIBOR-transition exposure, and faces REIT qualification, regulatory, environmental, tenant-replacement, and property-market risks. Management reported no material litigation or known material environmental liability. The company and auditor reported effective internal controls, and the auditor issued an unqualified opinion.
  • Unusual item: 2018 other comprehensive loss included a $3.7 million reduction in the fair value of interest-rate swaps; the filing estimated another $0.7 million would be reclassified to interest expense in 2019.

Important Facts for Investors to Verify

  • Confirm that this Global Medical REIT filing—not a Chiron Real Estate filing—is the intended company and reporting period.
  • Review the $636.0 million versus $636.1 million total-assets discrepancy and the conflicting East Valley acquisition status.
  • Assess recurring earnings and dividend coverage apart from the $7.7 million property-sale gain; compare the $0.80 common dividend with $0.76 AFFO per share and the distribution covenant.
  • Check available borrowing capacity, covenant headroom, debt maturities, hedging coverage, and sensitivity to rates and the LIBOR transition.
  • Monitor major-tenant and geographic concentrations, upcoming lease expirations, and tenants’ exposure to reimbursement and regulatory changes.